RespireRx Pharmaceuticals Inc (RSPI):企業の財務・戦略的SWOT分析

◆英語タイトル:RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH63437FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

RespireRx Pharmaceuticals Inc (RSPI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc. involved in the discovery, development and commercialization of innovative products for the treatment of various respiratory disorders (RD) and CNS problems. RespireRx focuses on attention deficit hyperactivity disorder, obstructive sleep apnea (OSA), spinal cord injury and other neurological disorders. The company’s lead product is Dronabinol, an oral capsule drug product which is being evaluated for the treatment of OSA. The company’s other pipeline products include CX1739, CX717, CX1942 and others. RespireRx is headquartered in Glen Rock, New Jersey, the US.

RespireRx Pharmaceuticals Inc Key Recent Developments

Oct 27,2020: RespireRx Pharmaceuticals announces appointment of Dr. James Cook and Dr. Jeffrey Witkin as Research Fellows
Sep 25,2020: RespireRx Pharmaceuticals announces appointment of David Dickason as Senior Vice President pre-clinical product development
Aug 03,2020: RespireRx Pharmaceuticals announces extension to long-term employment contract with Tim Jones as President and Chief Executive Officer
Feb 03,2020: RespireRx Pharmaceuticals announces appointment of Tim Jones to its Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
RespireRx Pharmaceuticals Inc – Key Facts
RespireRx Pharmaceuticals Inc – Key Employees
RespireRx Pharmaceuticals Inc – Key Employee Biographies
RespireRx Pharmaceuticals Inc – Major Products and Services
RespireRx Pharmaceuticals Inc – History
RespireRx Pharmaceuticals Inc – Company Statement
RespireRx Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
RespireRx Pharmaceuticals Inc – Business Description
RespireRx Pharmaceuticals Inc – Corporate Strategy
RespireRx Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
RespireRx Pharmaceuticals Inc – Strengths
RespireRx Pharmaceuticals Inc – Weaknesses
RespireRx Pharmaceuticals Inc – Opportunities
RespireRx Pharmaceuticals Inc – Threats
RespireRx Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
RespireRx Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 27, 2020: RespireRx Pharmaceuticals announces appointment of Dr. James Cook and Dr. Jeffrey Witkin as Research Fellows
Sep 25, 2020: RespireRx Pharmaceuticals announces appointment of David Dickason as Senior Vice President pre-clinical product development
Aug 03, 2020: RespireRx Pharmaceuticals announces extension to long-term employment contract with Tim Jones as President and Chief Executive Officer
Feb 03, 2020: RespireRx Pharmaceuticals announces appointment of Tim Jones to its Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
RespireRx Pharmaceuticals Inc, Key Facts
RespireRx Pharmaceuticals Inc, Key Employees
RespireRx Pharmaceuticals Inc, Key Employee Biographies
RespireRx Pharmaceuticals Inc, Major Products and Services
RespireRx Pharmaceuticals Inc, History
RespireRx Pharmaceuticals Inc, Subsidiaries
RespireRx Pharmaceuticals Inc, Key Competitors
RespireRx Pharmaceuticals Inc, Ratios based on current share price
RespireRx Pharmaceuticals Inc, Annual Ratios
RespireRx Pharmaceuticals Inc, Annual Ratios (Cont...1)
RespireRx Pharmaceuticals Inc, Interim Ratios
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
RespireRx Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[RespireRx Pharmaceuticals Inc (RSPI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Peptilogics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptilogics Inc (Peptilogics) is an early-stage biotechnology company that develops novel peptide therapeutics. The company’s antibiotics address the epidemic of multidrug-resistant bacterial infections. Its products portfolio includes engineered Cationic Antibiotic Peptides (eCAP) technolog …
  • ISMT Limited:企業の戦略・SWOT・財務情報
    ISMT Limited - Strategy, SWOT and Corporate Finance Report Summary ISMT Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Porto Seguro SA:企業の戦略・SWOT・財務分析
    Porto Seguro SA - Strategy, SWOT and Corporate Finance Report Summary Porto Seguro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Karelia Tobacco Company Inc SA:企業の戦略・SWOT・財務情報
    Karelia Tobacco Company Inc SA - Strategy, SWOT and Corporate Finance Report Summary Karelia Tobacco Company Inc SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • BYD Co Ltd (1211):電力:M&Aディール及び事業提携情報
    Summary BYD Co Ltd (BYD) designs, manufactures and sells rechargeable batteries, photovoltaic products, handset components, and other electronic products. It also offers whole product assembly services. The company manufactures and offers traditional fuel-engine vehicles and new energy vehicles. The …
  • Lukoil Oil Co (LKOH):電力:M&Aディール及び事業提携情報
    Summary Lukoil Oil Company (Lukoil) is a vertically integrated oil and gas company, which carries out exploration and production of crude oil and natural gas. Lukoil has interest in properties across Russia, Kazakhstan, Azerbaijan, Uzbekistan, the Middle East, South America, Northern and Western Afr …
  • Passenger Rail Agency of South Africa:企業の戦略的SWOT分析
    Passenger Rail Agency of South Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Celldex Therapeutics Inc (CLDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Celldex Therapeutics Inc (Celldex) is a bio-pharmaceutical company that discovers, develops and commercializes targeted immunotherapy technologies and cancer-targeting biologicsfor the treatment of various types of cancers. The company’s developmental pipeline comprises therapeutic antibodie …
  • Reckitt Benckiser Group Plc (RB.):企業の財務・戦略的SWOT分析
    Reckitt Benckiser Group Plc (RB.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Adamas Pharmaceuticals Inc (ADMS):製薬・医療:M&Aディール及び事業提携情報
    Summary Adamas Pharmaceuticals Inc (Adamas Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for chronic disorders of the central nervous system. The company's Gocovri, formerly ADS-5102, is an amantadine extended-release (XR) formulation for the treatment fo …
  • Spectris Plc (SXS):企業の財務・戦略的SWOT分析
    Spectris Plc (SXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • JG Summit Holdings Inc:戦略・SWOT・企業財務分析
    JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Wilson Vale:企業の戦略・SWOT・財務情報
    Wilson Vale - Strategy, SWOT and Corporate Finance Report Summary Wilson Vale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SBM Offshore NV (SBMO):企業の財務・戦略的SWOT分析
    SBM Offshore NV (SBMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Essilor International Compagnie Generale d’Optique SA (EI):医療機器:M&Aディール及び事業提携情報
    Summary Essilor International Compagnie Generale d'Optique SA (Essilor) designs, manufactures and distributes ophthalmic lenses, sunwear, reading glasses and optics equipment. The company offers a range of corrective lenses for correcting visual disorders such as myopia, hypermetropia and astigmatis …
  • Kirloskar Brothers Ltd (KIRLOSBROS):企業の財務・戦略的SWOT分析
    Kirloskar Brothers Ltd (KIRLOSBROS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • genOway SA (ALGEN):企業の財務・戦略的SWOT分析
    genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Buck Institute for Research on Aging:製薬・医療:M&Aディール及び事業提携情報
    Summary Buck Institute for Research on Aging (Buck Institute) is a biomedical institute that conducts research on aging and chronic disease. The institute concentrates on understanding the connection between aging and chronic disease. It carries out research and develops treatments in the therapeuti …
  • Harvard Stem Cell Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Harvard Stem Cell Institute (HSCI) a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, core …
  • Jupiter Energy Ltd (JPR):企業の財務・戦略的SWOT分析
    Summary Jupiter Energy Ltd (Jupiter Energy) is an oil exploration and production company. The company carries out acquisition, exploration, production, and develops oil and natural gas properties. Jupiter Energy holds an exploration permit in the oil-rich Mangistau Basin in West Kazakhstan. It also …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆